Subsidies
Subsidies
subsidy
| Title | Code of transcript | Funder | Beneficiary Entity | Call for applications | Date of award | Amount Awarded | Other Funds |
|---|---|---|---|---|---|---|---|
| Multispectral immunophenotyping of the tumor microenvironment in patients with high serous ovarian cancer Degree and its relationship to PARP inhibitor response/resistance (PARPi). | GN2024/02 | GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH | University of Navarra | 2024 GN Projects of research in health | 10-12-2024 | 79.982,00€ | - |
| Clinical development of IDP-121: a novel, first-in-class drug for microcytic lung cancer (MYCrocytic). | CPP2023-010510 | STATE INVESTIGATION AGENCY | University of Navarra | 2023 AEI PARTNERSHIP PUBLIC-PRIVATE | 09-12-2024 | 411.219,90€ | ERDF funds |
| USE OF MAGNESIUM COPRODUCTS TO FACILITATE THE Economics CIRCULAR IN URBAN WASTEWATER TREATMENT PLANTS THROUGH THE RECOVERY OF PHOSPHORUS IN THE FORM OF STRUVITE, BIOGAS UPGRADING AND FERTILIZER PRODUCTION. MagnEDAR | CPP2023-010703 | STATE INVESTIGATION AGENCY | University of Navarra | 2023 AEI PARTNERSHIP PUBLIC-PRIVATE | 09-12-2024 | 86.027,00€ | ERDF funds |
| research and development of surimi products suitable for fish allergy sufferers and packaged in compostable materials [FISH4ALL]. | CPP2023-010544 | STATE INVESTIGATION AGENCY | University of Navarra | 2023 AEI PARTNERSHIP PUBLIC-PRIVATE | 09-12-2024 | 369.033,75€ | ERDF funds |
| Lysosomal targeted degraders against EGFR for difficult-to-treat lung cancers (EGFR-LYTAC). | CPP2023-010665 | STATE INVESTIGATION AGENCY | University of Navarra | 2023 AEI PARTNERSHIP PUBLIC-PRIVATE | 09-12-2024 | 295.747,00€ | ERDF funds |
